Snowden Capital Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.66M | Sell |
9,021
-18
| -0.2% | -$5.35K | 0.07% | 279 |
|
|
2025
Q4 | $2.47M | Buy |
9,039
+1,181
| +15% | +$321K | 0.06% | 285 |
|
|
2025
Q3 | $2.12M | Buy |
7,858
+318
| +4% | +$86.5K | 0.06% | 309 |
|
|
2025
Q2 | $2.08M | Sell |
7,540
-212
| -3% | -$57.7K | 0.06% | 298 |
|
|
2025
Q1 | $2.06M | Sell |
7,752
-1,022
| -12% | -$252K | 0.07% | 295 |
|
|
2024
Q4 | $2.09M | Buy |
8,774
+1,733
| +25% | +$399K | 0.06% | 292 |
|
|
2024
Q3 | $1.55M | Sell |
7,041
-148
| -2% | -$30.6K | 0.05% | 389 |
|
|
2024
Q2 | $1.41M | Sell |
7,189
-78
| -1% | -$16.1K | 0.04% | 413 |
|
|
2024
Q1 | $1.56M | Buy |
7,267
+4,464
| +159% | +$938K | 0.05% | 382 |
|
|
2023
Q4 | $590K | Buy |
2,803
+592
| +27% | +$126K | 0.02% | 628 |
|
|
2023
Q3 | $443K | Sell |
2,211
-475
| -18% | -$94.4K | 0.02% | 702 |
|
|
2023
Q2 | $498K | Sell |
2,686
-48
| -2% | -$8.87K | 0.02% | 736 |
|
|
2023
Q1 | $524K | Buy |
2,734
+293
| +12% | +$53K | 0.02% | 715 |
|
|
2022
Q4 | $410K | Sell |
2,441
-352
| -13% | -$61.2K | 0.02% | 794 |
|
|
2022
Q3 | $494K | Sell |
2,793
-1,113
| -28% | -$220K | 0.02% | 655 |
|
|
2022
Q2 | $799K | Sell |
3,906
-29
| -0.7% | -$6.15K | 0.04% | 480 |
|
|
2022
Q1 | $936K | Buy |
3,935
+327
| +9% | +$76.8K | 0.04% | 457 |
|
|
2021
Q4 | $824K | Sell |
3,608
-270
| -7% | -$59.4K | 0.04% | 363 |
|
|
2021
Q3 | $750K | Sell |
3,878
-163
| -4% | -$33K | 0.04% | 429 |
|
|
2021
Q2 | $859K | Sell |
4,041
-28
| -0.7% | -$5.91K | 0.04% | 407 |
|
|
2021
Q1 | $831K | Sell |
4,069
-201
| -5% | -$39.6K | 0.05% | 381 |
|
|
2020
Q4 | $777K | Buy |
4,270
+49
| +1% | +$8.33K | 0.05% | 342 |
|
|
2020
Q3 | $706K | Buy |
4,221
+75
| +2% | +$12.6K | 0.06% | 319 |
|
|
2020
Q2 | $674K | Buy |
4,146
+398
| +11% | +$71.3K | 0.06% | 315 |
|
|
2020
Q1 | $648K | Sell |
3,748
-232
| -6% | -$46.2K | 0.07% | 299 |
|
|
2019
Q4 | $799K | Buy |
3,980
+22
| +0.6% | +$4.51K | 0.07% | 306 |
|
|
2019
Q3 | $836K | Buy |
3,958
+30
| +0.8% | +$6.27K | 0.08% | 272 |
|
|
2019
Q2 | $763K | Sell |
3,928
-24
| -0.6% | -$4.42K | 0.08% | 283 |
|
|
2019
Q1 | $650K | Buy |
3,952
+130
| +3% | +$23K | 0.07% | 298 |
|
|
2018
Q4 | $719K | Buy |
3,822
+79
| +2% | +$14.6K | 0.09% | 269 |
|
|
2018
Q3 | $637K | Buy |
3,743
+155
| +4% | +$26.1K | 0.07% | 296 |
|
|
2018
Q2 | $588K | Buy |
3,588
+37
| +1% | +$6.04K | 0.08% | 291 |
|
|
2018
Q1 | $574K | Buy |
3,551
+490
| +16% | +$78K | 0.08% | 249 |
|
|
2017
Q4 | $447K | Buy |
3,061
+1,549
| +102% | +$221K | 0.06% | 291 |
|
|
2017
Q3 | $205K | Sell |
1,512
-143
| -9% | -$18.1K | 0.03% | 367 |
|
|
2017
Q2 | $207K | Sell |
1,655
-247
| -13% | -$29.5K | 0.04% | 333 |
|
|
2017
Q1 | $226K | Buy |
+1,902
| New | +$229K | 0.05% | 303 |
|
Other funds holding CME
VCM
VPM
Snowden Capital Advisors's CME Position: Q1 2026 in Review
Snowden Capital Advisors reduced its CME Group (CME) stake by 0.2% in Q1 2026, selling an estimated $5.35K and leaving 9,021 shares worth $2.66M. The position accounts for 0.07% of the portfolio, ranked #279.
Snowden Capital Advisors first reported a position in CME in Q1 2017 and has held it in 37 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Snowden Capital Advisors held 9,021 shares of CME Group worth $2.66M as of Q1 2026.
- Snowden Capital Advisors sold 18 CME Group shares in Q1 2026, an estimated $5.35K.
- CME Group made up 0.07% of Snowden Capital Advisors's portfolio in Q1 2026, its #279 holding.
- Snowden Capital Advisors first reported a position in CME Group in Q1 2017 and has held it in 37 quarters since.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.